Category Specific: IT

164: Black Belt Procurement: The Power of Maintained Focus w/ Lawrence Kane

My guest today is Lawrence Kane, a Fortune 50 strategic sourcing and functional excellence lead. Lawrence and I sat down to talk at the SIG Fall Summit in Carlsbad, California, where our conversation focused on what he has learned during his three-decade career.

To be successful you have to have empathy, you have to have people skills, you have to emotionally engage folks so that they want to be part of the solution. – Lawrence Kane

Highlights from the Show Include:

  • How learning to resist the adrenaline rush keeps emotion from overcoming productivity in a negotiation.
  • Why to be successful you have to have empathy, people skills, you have to emotionally engage folks so that they want to be part of the solution.
  • Lawrence explains that procurement doesn’t have to be the world’s greatest technical expert, but we have to know enough to see what’s real and what’s not real.
  • On the journey to becoming a trusted advisor, procurement needs to know the company well enough to understand what’s not going well, what can be done better, and where there are opportunities folks haven’t thought of yet.

Links and Resources:

About the author

Philip Ideson

Philip Ideson is passionate about the role that procurement professionals and leaders can plan in creating competitive advantage for their organizations in ways that go beyond the traditional value proposition.

Philip founded Art of Procurement as a way for the procurement community to learn from each other, increasing the impact they have on their organizations. In 2017, he co-founded Palambridge, a virtual platform of procurement experts, technology, and intelligence. Palambridge provides a broad range of flexible procurement solutions, available on-demand.

Prior to Art of Procurement and Palambridge, Philip enjoyed a career that spanned the procurement value chain, working across three continents for organizations such as Accenture, Procurian, Ally Financial, Pfizer and Ford Motor Company.